Education
About Us
Working with TipRanks
Follow Us
Barbara Gayle Duncan Insider Profile
4 Followers
Barbara Gayle Duncan, CFO at Intercept Pharma, holds 24.89K shares in Intercept Pharma (Ticker: ICPT), holds ― shares in Adaptimmune Therapeutics (Ticker: ADAP), holds 0.00 shares in Innoviva (Ticker: INVA). Most recently, Barbara Gayle Duncan Sold ― shares of Intercept Pharma on Oct 05, 2016 for an estimated value of 23.99K.
Profitable Transactions
6 out of 7 Profitable Transactions
Average Return
+24.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Barbara Gayle Duncan holds in companies
Most Profitable Insider Trade
Stock:
Intercept Pharma
(ICPT)
(ICPT)
Rating:Informative Sell
Date:Apr 01, 2015 - Apr 01, 2016
Return:+52.70%
The most profitable trade made by Barbara Gayle Duncan
Barbara Gayle Duncan's Trading History
Intercept Pharma
Oct 05, 2016
―
Informative Sell
23.99K
$472.95K
Adaptimmune Therapeutics
―
Director
―
―
Innoviva
Apr 24, 2017
Director
Uninformative Buy
―
$0.00
Jounce Therapeutics
―
―
―
$0.00
Ovid Therapeutics
―
Director
―
―
Immunomedics
Oct 23, 2020
―
Uninformative Sell
―
$0.00
Atea Pharmaceuticals
Jun 18, 2024
Director
Uninformative Buy
119.67K
$99.12K
Fusion Pharmaceuticals
―
―
―
―
Halozyme
Apr 29, 2024
Director
Uninformative Buy
―
$960.68K
Aevi Genomic Medicine
Oct 18, 2017
―
Informative Buy
75.00K
$0.00
List of latest transactions for each holding click on a transaction to see Barbara Gayle Duncan's performance on stock
You May Also Like
Barbara Gayle Duncan insider profile FAQ
What is the percentage of profitable transactions made by Barbara Gayle Duncan?
The percentage of profitable transactions made by Barbara Gayle Duncan is 86%.
What is the average return per transaction made by Barbara Gayle Duncan?
The average return per transaction made by Barbara Gayle Duncan is 24.90%.
What stocks does Barbara Gayle Duncan hold?
Barbara Gayle Duncan holds: ICPT, ADAP, INVA, JNCE, OVID, IMMU, AVIR, FUSN, HALO, GNMX stocks.
What was Barbara Gayle Duncan’s latest transaction?
Barbara Gayle Duncan latest transaction was an Informative Sell of $23.99K.
What was Barbara Gayle Duncan's most profitable transaction?
Barbara Gayle Duncan’s most profitable transaction was an Informative Sell of ICPT stock on April 1, 2015. The return on the trade was 52.70%.
What is Barbara Gayle Duncan's role in Intercept Pharma?
Barbara Gayle Duncan's role in Intercept Pharma is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.